Acute Renal Failure

ARF Can Be First Sign of Myeloma

Caroline Helwick February 05, 2010

NEW ORLEANS—Acute renal failure (ARF) induced by pathogenic light chains can be the first presenting sign of multiple myeloma, and prompt treatment of the malignancy is critical to reversing renal damage, according to a study presented by European investigators at the American Society of Hematology 51st annual meeting.
 

Donor ARF Need Not Stop Renal Transplants

Jill Stein October 08, 2009

Acute renal damage may resolve in the absence of the underlying cause.
 

Women Fare Better After Severe Trauma

Rosemary Frei, MSc September 11, 2009

They are less likely than men to suffer acute renal failure and other complications, researchers say.
 

A Downside to Angiotensin Blockade?

Delicia Honen Yard June 18, 2009

Researcher Macaulay Onuigbo, MD, MSc, proposes that ACE inhibitors and angiotensin receptor blockers can cause renal failure.
 

Study: ARF Risk Greater with CABG

Caroline Helwick June 15, 2009

ORLANDO—Acute renal failure (ARF) may be more likely to develop following coronary artery bypass grafting (CABG) than percutaneous coronary intervention (PCI), according to researchers.
 

Anemia

Higher Hemoglobin Found Beneficial

Jody A. Charnow December 17, 2009

After 36 months of follow-up, patients were 26% less likely to die or start dialysis, study finds.
 

CKD, Anemia, Microalbuminuria Increase Death Risk

Jody A. Charnow December 17, 2009

SAN DIEGO—Anemia, CKD, and microalbuminuria are each independently associated with an increased risk of all-cause mortality, regardless of the presence of cardiovascular disease (CVD).
 

Hepcidin Predicts Hemoglobin Response to Iron Loading

Jody A. Charnow December 17, 2009

Researchers also show that administration of erythropoietin is followed by marked reductions in circulating hepcidin.
 

A Possible Reason for ESA Resistance

Jody A. Charnow December 17, 2009

Investigators believe elevated levels of endogenous soluble erythropoietin receptors may have a role.
 

A New Look at High Hb Goals

Jody A. Charnow December 10, 2009

Heart failure and diabetes could make reported risks clinically undetectable.
 

Chronic Kidney Disease

Impaired Renal Function Raises Risk of Advanced Coronary Atherosclerosis

Jody A. Charnow March 02, 2010

Coronary atherosclerosis severity is significantly associated with decreased renal function, according to researchers.
 

Proteinuria Is A Key Determinant of Outcomes

Jody A. Charnow February 08, 2010

Adverse clinical outcomes associated with a given level of estimated glomerular filtration rate (eGFR) vary substantially based on the presence and severity of proteinuria, according to Canadian researchers.
 

The '30-20-10' Rule for Renal Care

Kevin E. Chan, MD, MSc, Raymond M. Hakim, MD, PhD, Joseph Pulliam, MD January 22, 2010

Nephrologists propose critical action eGFR thresholds to guide management of kidney disease patients.
 

Diet Soda, Salt May Harm Kidneys

Jody A. Charnow January 22, 2010

Two or more servings per day found to double the risk of a 30% or greater decline in eGFR.
 

Albuminuria and Heart Disease Linked Only in White Diabetics

John Schieszer January 22, 2010

Albuminuria is strongly associated with the severity of calcified atherosclerotic plaque (CP) in white but not black individuals with type 2 diabetes, according to a new study.
 

Contrast Nephropathy

High Incidence of Contrast-Induced Nephropathy Found

Jody A. Charnow January 15, 2010

Contrast-induced nephropathy (CIN) develops in 11% of emergency department patients who undergo contrast-enhanced CT (CECT), according to a study published in the Clinical Journal of the American Society of Nephrology (2009; published online ahead of print).
 

Sodium Bicarbonate Does Not Decrease CIN Risk

Jody A. Charnow October 16, 2009

A recent study shows that sodium bicarbonate is no better than saline in preventing contrast-induced nephropathy (CIN).
 

CIN May Have a Causal Role in Long-Term Adverse Events

Jody A. Charnow July 23, 2009

Evidence comes from a study comparing two strategies for preventing contrast-induced nephropathy
 

CIN Prevention Remains a Challenge

Sankar D. Navaneethan, MD, MPH April 07, 2009

Contrast-induced nephropathy (CIN), defined as a rise in serum creatinine greater than 0.5 mg/dL or a level greater than 25% from baseline following use of intravascular contrast media, is increasing.
 

Trial for Fluid Replacement System and CIN Prevention

William Weber January 22, 2009

PLC Medical Systems, Inc., of Franklin, Mass., has received full approval for a U.S. pivotal trial to study the effectiveness of its RenalGuard System and associated therapy in the prevention of contrast-induced nephropathy (CIN).
 

Diabetes

Spironolactone May Help Hypertensive Diabetics

Jody A. Charnow March 02, 2010

Adding spironolactone to a regimen that includes maximal ACE inhibition improves renoprotection in hypertensive patients with diabetic nephropathy, data suggest.
 

Walnuts May Benefit Type 2 Diabetics

Jody A. Charnow February 22, 2010

Eating walnuts may improve endothelial function in patients with type 2 diabetes, data suggest.
 

HbA1c Recommended To Diagnose Diabetes

Delicia Honen Yard January 27, 2010

Hemoglobin A1c (HbA1c) should be used to diagnose diabetes and prediabetes, according to new recommendations from the American Diabetes Association (ADA).
 

Albuminuria and Heart Disease Linked Only in White Diabetics

John Schieszer January 22, 2010

Albuminuria is strongly associated with the severity of calcified atherosclerotic plaque (CP) in white but not black individuals with type 2 diabetes, according to a new study.
 

Napping May Raise Diabetes Risk

Jody A. Charnow January 15, 2010

Day napping and short night sleeping are associated with an elevated risk of diabetes among older adults, researchers reported in Diabetes Care (2009; published online ahead of print).
 

Diabetic Nephropathy

Spironolactone Improves Renoprotection in Patients with Diabetes and Hypertension

Jody A. Charnow January 04, 2010

Adding spironolactone to a regimen that includes maximal ACE inhibition improves renoprotection in patients with diabetic nephropathy, data suggest.
 

New Biomarkers of Diabetic Nephropathy

Susanne B. Nicholas, MD, PhD October 22, 2009

Cell adhesion molecules may be potential targets for therapeutic intervention to delay CKD progression.
 

Megadosage Candesartan Beneficial

Jody A. Charnow February 18, 2009

Renal disease patients who have persistent proteinuria despite treatment with the highest approved dosage of the angiotensin receptor blocker candesartan may benefit from higher dosages, a Canadian study finds.
 

Predictors of Cardiac Events After Renal Transplantation

Jody A. Charnow November 01, 2008

Diabetic nephropathy and CVD prior to renal transplantation are the most important predictors of post-transplant cardiovascular events, researchers in The Netherlands conclude.
 

U.K. Team: GFR Estimates Important

Jill Stein September 01, 2008

SAN FRANCISCO—British researchers have endorsed U.S. guidelines stating that screening diabetic patients for renal disease should involve estimated glomerular filtration rate (eGFR) in addition to testing for albuminuria.
 

Focal Segmental Glomerulosclerosis

Steroids May Harm Athletes' Kidneys

John Schieszer March 02, 2010

Serious renal damage is a possible consequence of long-term abuse of anabolic steroids, data show .
 

Mycophenolate Mofetil Works As Well As Standard Therapy

Jody A. Charnow July 22, 2008

Six months of mycophenolate mofetil (MMF) treatment is as effective in the short term as conventional therapy for primary treatment of membranous nephropathy (MN) and focal segmental glomerulosclerosis (FSGS), a pilot study in India found.
 

MMF Similar to Conventional Therapies for MN, FSGS

Jody A. Charnow January 01, 2008

A six-month course of treatment with mycophenolate mofetil (MMF) is as effective as conventional therapies for treating membranous nephropathy (MN) and focal segmental glomerulosclerosis (FSGS), according to a pilot study conducted in India.
 

Diagnosing, Treating FSGS: An Update

March 01, 2007

FOCAL SEGMENTAL glomerulosclerosis (FSGS) is not a single disease but a histologic pattern of renal damage that initially affects the glomerulus and its tubulointerstitium (Nat Clin Pract Nephrol. 2005;1:44-54). FSGS is a leading cause of nephrotic syndrome worldwide and may be found in up to 35% of nephrotic individuals.
 

Study Reveals Epidemiology of Glomerulopathies in Brazil

January 01, 2007

Five-year data gathered by the Paulista Registry of Glomerulopathies in São Paulo, Brazil, shows that focal and segmental glomerulosclerosis is the most common primary glomerular disease, followed by membranous nephropathy and IgA nephropathy.
 

Hemodialysis

Hemodialysis Patient Outcomes After Long-Term Care Hospital Stays

Jody A. Charnow March 02, 2010

Most hemodialysis (HD) patients admitted to a long-term care hospital (LTCH) are either re-admitted to acute-care hospitals or require nursing home placement, according to researchers.
 

Nocturnal Hemodialysis Superior for Phosphate Lowering

Jody A. Charnow March 02, 2010

Patients who undergo nocturnal hemodialysis (NHD) experience significant decreases in serum phosphate compared with patients on conventional hemodialysis (HD), despite a reduction in the use of phosphate binders, according to Canadian researchers.
 

Black HD Patients Benefit More from Obesity

Tasheema Prince March 02, 2010

Obesity is associated with greater survival in African-American maintenance hemodialysis (MHD) patients compared with other races, according to a study.
 

Fatigue Increases Cardiovascular Risk in ESRD Patients

Jody A. Charnow February 25, 2010

Cardiovascular events are twice as likely to occur in highly fatigued patients, recent study shows.
 

Thrombolytic Drug Improves Hemodialysis Catheter Function

Jody A. Charnow February 17, 2010

Tenecteplase, a thrombolytic agent, is a safe and effective treatment for dysfunctional tunneled hemodialysis (HD) catheters, according to researchers.
 

Hypertension

Spironolactone May Help Hypertensive Diabetics

Jody A. Charnow March 02, 2010

Adding spironolactone to a regimen that includes maximal ACE inhibition improves renoprotection in hypertensive patients with diabetic nephropathy, data suggest.
 

BP Drug Combination May Offer Better Renoprotection

Jody A. Charnow February 17, 2010

Use of benazepril with amlodipine rather than hydrochlorothiazide is more effective at slowing CKD progression.
 

ACE Inhibitors, Angiotensin Receptor Blockers Have Heart Benefits in Hemodialysis Patients

February 16, 2010

Study finds that the drugs reduce left ventricular mass.
 

Hypertension, Fructose Intake Linked

John Schieszer January 22, 2010

Those who consume 74 grams or more of fructose daily are at higher risk than those who consume less.
 

Cocoa Can Decrease Blood Pressure, Study Shows

Jody A. Charnow January 05, 2010

Cocoa products such as dark chocolate and cocoa-containing beverages can lower blood pressure, a recent meta-analysis confirms.
 

Kidney Cancer

Renal Cell Carinoma Type Tied to Time on Dialysis

Jody A. Charnow March 02, 2010

The histologic type of renal cell carcinoma (RCC) arising in patients with end-stage renal disease (ESRD) may be related to the time on dialysis, according to a study.
 

Excellent Short-Term Outcomes Reported for RAPN

Jody A. Charnow March 02, 2010

Robot-assisted partial nephrectomy (RAPN) is a safe and effective approach for nephron-sparing surgery (NSS) that is capable of providing patients with excellent short-term oncologic outcomes, according to the largest RAPN experience described to date.
 

Pre-Nephrectomy Sorafenib Shrinks Renal Cancer Tumors

John Schieszer February 25, 2010

Administering sorafenib prior to nephrectomy for renal cell carcinoma (RCC) can reduce the size of the primary tumor with adding to the risk of surgery, according to researchers at the University of North Carolina at Chapel Hill.
 

Renal Cancer Is More Likely in Obese Individuals

Delicia Honen Yard February 16, 2010

Obese individuals with kidney tumors are 48% more likely to develop a clear-cell renal cell carcinoma (RCC) than non-obese individuals, researchers reported in BJU International (2010;105:16-20).
 

Excellent Short-Term Outcomes Reported for Robot-Assisted Partial Nephrectomy

Jody A. Charnow January 27, 2010

Robot-assisted partial nephrectomy (RAPN) is a safe and effective approach for nephron-sparing surgery (NSS) that is capable of providing patients with excellent short-term oncologic outcomes, according to the largest RAPN experience described to date.
 

Kidney Stones

Kidney Stone Disease Tied to Obesity

Jody A. Charnow February 16, 2010

During a five-year period, stones were diagnosed in 4.9% of obese and 2.6% of non-obese subjects.
 

Study Identifies Predictors of CKD in Stone Formers

Jody A. Charnow January 15, 2010

Diabetes, hypertension, frequent UTIs, the formation of struvite stones, and allopurinol use may predict the development of CKD among individuals who have had kidney stones, researchers reported in the American Journal of Kidney Diseases (2009; published online ahead of print).
 

Study Identifies Predictors of CKD in Stone Formers

Jody A. Charnow November 23, 2009

Among individuals who have had kidney stones, diabetes, hypertension, frequent UTIs, the formation of struvite stones, and allopurinol use may predict the development of CKD, according to researchers.
 

Lithostat for Struvite Stones Reintroduced

Jody A. Charnow November 19, 2009

Lithostat (acetohydroxamic acid), the only urease inhibitor available for urea-splitting urinary infections in association with struvite stones, is available again at pharmacies nationwide, according to the drug's marketer, Mission Pharmacal.
 

Healthy Diet May Lower Kidney Stone Risk

Jody A. Charnow October 16, 2009

The protective effect of a DASH-style diet was similar for men and women regardless of age and BMI.
 

Lupus Nephritis

Kidney Transplants Generally Safe for Lupus Patients

John Schieszer October 31, 2009

Contrary to previous studies, lupus patients who receive kidney transplants rarely develop lupus nephritis in their new allograft, according to a study presented at ASN's Renal Week conference.
 

Rituximab Eases Lupus Nephritis

Jody A. Charnow September 21, 2009

Rituximab is an effective treatment for lupus nephritis that enables reductions in maintenance steroids, data show.
 

Fatal Infections Probed in Pediatric LN Patients

Jody A. Charnow May 07, 2009

Prior history of treatment with pulse methylprednisolone may increase the risk of fatal infection in pediatric lupus nephritis (LN) patients treated with IV cyclophosphamide (IVCY), researchers reported.
 

Active Lupus Nephritis Raises Pregnancy Risks

Jody A. Charnow March 23, 2009

Pregnant patients with active lupus nephritis have a higher incidence of maternal and fetal complications compared with patients who have systemic lupus erythematosus (SLE) without renal involvement, researchers reported in Lupus (2009;18:342-347).
 

Secondary Hyperparathyroidism

Parathyroid Gland Size May Affect Cinacalcet Response

Jody A. Charnow January 15, 2010

Parathyroid gland enlargement may delay the response of secondary hyperparathyroidism to cinacalcet, Japanese researchers reported in Nephron Clinical Practice (2009; published online ahead of print).
 

Researchers Link Elevated PTH to High Uric Acid

Eric Butterman November 01, 2009

Elevated serum parathyroid hormone levels are associated with higher serum uric acid levels in the U.S. adult population, investigators reported at ASN's Renal Week 2009.
 

Specialty Pharmacy Improves Control of Secondary Hyperparathyroidism

Eric Butterman November 01, 2009

Participation in a specialty pharmacy improved control of secondary hyperparathyroidism in hemodialysis patients, researchers reported at ASN's Renal Week 2009.
 

Cinacalcet Safely Treats Persistent Post-Kidney-Transplant Hyperparathyroidism

Eric Butterman November 01, 2009

Cinacalcet therapy is safe and effective for treating persistent hyperparathyroidism after renal transplantation, British researchers reported at ASN's Renal Week 2009. The medication is not associated with allograft dysfunction or significant adverse effects.
 

Elevated Parathyroid Hormone Linked to Obesity in CKD Patients

Eric Butterman November 01, 2009

Obesity in CKD patients is associated with increased parathyroid hormone levels independent of estimated glomerular filtration rate, according to a study presented at ASN's Renal Week 2009.
 

Transplantation

Live Kidney Donation Does Not Shorten Survival

Jody A. Charnow March 10, 2010

Within 12 months of surgery, their death rate was similar to that of healthy controls, study finds.
 

Wyeth Makes Drug Monitoring Changes for Sirolimus

Jody A. Charnow March 02, 2010

Wyeth has notified health care professionals of changes to the Rapamune (sirolimus) prescribing information related to changes in the performance of an immunoassay used for therapeutic drug monitoring (TDM) of the medication, according to the FDA.
 

Expanding the Kidney Donor Pool

Heidi M. Schaefer, MD March 02, 2010

Strategies include the use of non-standard-criteria kidney donation and kidney-exchange programs.
 

ECD Kidneys Are Underused in Older Patients

John Schieszer February 22, 2010

One third of those who can benefit are not waitlisted for the organs.
 

Kidney Allocation Policy May Need Rethinking

John Schieszer February 12, 2010

De-emphasis on HLA matching could lead to worse outcomes in highly sensitized patients,
 
 Subscribe to the RSS for this page  [view all our RSS feeds here]